Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-000171
Filing Date
2023-01-03
Accepted
2023-01-03 21:23:11
Documents
1
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 form4-01042023_020102.html 4  
1 form4-01042023_020102.xml 4 3619
  Complete submission text file 0001415889-23-000171.txt   4984
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017
Business Address
Rowe Michael M (Reporting) CIK: 0001744774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 23504179